Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 6
Submit an article Journal homepage
161
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

Patrick MarcellinHôpital Beaujon, 100 Boulevard Du General Leclerc, Clichy, 92110, France+33 1 40 87 53 38; [email protected]
,
Stuart K RobertsThe Alfred Hospital, Prahan, VIC, Australia
,
K Rajender ReddyUniversity of Pennsylvania, Philadelphia, PA, USA
,
Stephen A HarrisonBrooke Army Medical Center, Fort Sam Houston, TX, USA
,
Donald M JensenCenter for Liver Diseases, Chicago, IL, USA
,
Stephanos HadziyannisHenry Dunant Hospital, Athens, Greece
,
Moises DiagoHospital General de Valencia, Valencia, Spain
,
Martin WeltmanNepean Hospital, Sydney, NSW, Australia
,
Diethelm MessingerIST GmbH, Mannheim, Germany
,
Fernando Tatsch Roche, Basel, Switzerland
&
Mario RizzettoUniversity of Torino, Torino, Italy
 show all
Pages 901-909 | Published online: 04 Sep 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yousef Fazel, Brian Lam, Pegah Golabi & Zobair Younossi. (2015) Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C. Expert Opinion on Drug Safety 14:8, pages 1317-1326.
Read now
Minkyoung Yoo, Yan Cheng, Taylor J Rhien & Joseph Biskupiak. (2014) Current issues in comparative effectiveness research for hepatitis C. Comparative Effectiveness Research 4, pages 13-27.
Read now

Articles from other publishers (2)

Simona Francioso, Cristiana Almerighi, Paolo Forte, Franco Bandiera, Lorenzo Nosotti, Raffaella Lionetti, Gloria Taliani, Maria Rosaria Piras, Maria Laura Ponti, Giustino Parruti, Francesco Di Candilo, Silvia Gentile, Paola Piccolo, Angela Salso, Francesca Riccobelli, Sara Renzi, Maria Antonella Longo, Marzia Montalbano, Salvatore Zaru, Elisa Biliotti, Francesco Di Masi, Francesco Santopaolo & Mario Angelico. (2014) A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial. Digestive and Liver Disease 46:2, pages 164-169.
Crossref
Peter N. Morcos, Linda Chang, Rohit Kulkarni, Mylene Giraudon, Nancy Shulman, Barbara J. Brennan, Patrick F. Smith & Jonathan Q. Tran. (2013) A randomised study of the effect of danoprevir/ritonavir or ritonavir on substrates of cytochrome P450 (CYP) 3A and 2C9 in chronic hepatitis C patients using a drug cocktail. European Journal of Clinical Pharmacology 69:11, pages 1939-1949.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.